Funding opportunity for Innovative Research in Cancer Nanotechnology



The NCI has a funding opportunity for Innovative Research in Cancer Nanotechnology (IRCN). The NCI is offering new grant awards (up to $450k/yr for up to 5 years; multiple receipt dates) for multidisciplinary studies proposing to expand the fundamental understanding of the processes pertinent to the use of nanotechnology in cancer research and clinical care (PAR-14-285). These Innovative Research in Cancer Nanotechnology (IRCN) awards will be an integral part of the NCI Alliance for Nanotechnology in Cancer program.